Addex Therapeutics Ltd ADR (ADXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,121 | 8,015 | -11,759 | -21,801 | -16,797 |
| Depreciation Amortization | 10 | 296 | 341 | 339 | 380 |
| Accounts receivable | -6 | 106 | 341 | -264 | -106 |
| Accounts payable and accrued liabilities | 472 | -1,302 | -683 | -448 | 967 |
| Other Working Capital | 663 | -1,395 | 238 | 165 | -653 |
| Other Operating Activity | 4,361 | -11,823 | 2,619 | 4,785 | 119 |
| Operating Cash Flow | $-2,621 | $-6,104 | $-8,903 | $-17,225 | $-16,089 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -614 | N/A | N/A | N/A | N/A |
| PPE Investments | N/A | -1 | -8 | -1 | -35 |
| Purchase Of Investment | -345 | N/A | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | 4 | 1 |
| Other Investing Activity | 138 | 5,278 | 0 | 0 | 0 |
| Investing Cash Flow | $-822 | $5,277 | $-8 | $3 | $-33 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 274 | 6,426 | 4,760 | 17,103 |
| Common Stock Repurchased | 1,483 | N/A | -44 | N/A | 4,154 |
| Other Financing Activity | -54 | -154 | -518 | -1,509 | -3,310 |
| Financing Cash Flow | $1,429 | $119 | $5,864 | $3,251 | $17,946 |
| Exchange Rate Effect | -43 | 113 | -398 | -206 | 134 |
| Beginning Cash Position | 4,034 | 4,391 | 7,750 | 21,466 | 20,454 |
| End Cash Position | 1,978 | 3,796 | 4,306 | 7,290 | 22,413 |
| Net Cash Flow | $-2,056 | $-595 | $-3,444 | $-14,176 | $1,958 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,621 | -6,104 | -8,903 | -17,225 | -16,089 |
| Capital Expenditure | N/A | -1 | -8 | -1 | -35 |
| Free Cash Flow | -2,621 | -6,105 | -8,910 | -17,225 | -16,123 |